Hereditary breast and ovarian cancer: review and future perspectives (Q36311502)

13 August 2017

1 reference

title

Hereditary breast and ovarian cancer: review and future perspectives (English)

1 reference

13 August 2017

1 reference

2

Peter A Fasching

1 reference

13 August 2017

3

Matthias W Beckmann

1 reference

13 August 2017

1

Michael P Lux

1 reference

13 August 2017

11 November 2005

1 reference

Journal of Molecular Medicine

13 August 2017

1 reference

13 August 2017

84

1 reference

13 August 2017

1

1 reference

13 August 2017

16-28

1 reference

https://scigraph.springernature.com/pub.10.1007/s00109-005-0696-7

13 August 2017

0 references

cites work

Cancer Incidence in BRCA1 mutation carriers

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0696-7

Breast MR imaging screening in 192 women proved or suspected to be carriers of a breast cancer susceptibility gene: preliminary results.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0696-7

Interim analysis of the incidence of breast cancer in the Royal Marsden Hospital tamoxifen randomised chemoprevention trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0696-7

Mortality associated with oral contraceptive use: 25 year follow up of cohort of 46 000 women from Royal College of General Practitioners' oral contraception study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00109-005-0696-7

Cost-effective treatment of women with advanced ovarian cancer by cytoreductive surgery and chemotherapy directed by an in vitro assay for drug resistance.

21 January 2018

1 reference

12 December 2020

Mutation and cancer: statistical study of retinoblastoma

1 reference

12 December 2020

Survival in prospectively ascertained familial breast cancer: Analysis of a series stratified by tumour characteristics,BRCAmutations and oophorectomy

1 reference

12 December 2020

Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium.

1 reference

12 December 2020

Familial invasive breast cancers: worse outcome related to BRCA1 mutations

1 reference

12 December 2020

Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

Hormone replacement therapy and ovarian cancer

1 reference

12 December 2020

Atypical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study

1 reference

12 December 2020

Breast reconstruction: current state of the art

1 reference

12 December 2020

Cell proliferation and apoptosis in BRCA-associated hereditary ovarian cancer

1 reference

12 December 2020

Clinical practice. Mammographic screening for breast cancer

1 reference

12 December 2020

Impact of germline BRCA1 mutations and overexpression of p53 on prognosis and response to treatment following breast carcinoma: 10-year follow up data

1 reference

12 December 2020

Effect of BRCA Mutations on the Length of Survival in Epithelial Ovarian Tumors

1 reference

12 December 2020

Cancer risks in BRCA2 mutation carriers

1 reference

12 December 2020

Age of uptake of early cancer detection facilities by low-risk and high-risk patients with familial breast and ovarian cancer

1 reference

12 December 2020

Parity, age at first childbirth, and risk of ovarian cancer

1 reference

12 December 2020

Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition

1 reference

12 December 2020

A new scoring system to differentiate benign from malignant adnexal masses

1 reference

12 December 2020

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group

1 reference

12 December 2020

Use of intensified early cancer detection in high-risk patients with familial breast and ovarian cancer

1 reference

12 December 2020

Projecting individualized probabilities of developing breast cancer for white females who are being examined annually

1 reference

12 December 2020

Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation

1 reference

12 December 2020

BRCA1 and BRCA2 in hereditary breast cancer

1 reference

12 December 2020

NIH consensus conference. Ovarian cancer. Screening, treatment, and follow-up. NIH Consensus Development Panel on Ovarian Cancer

1 reference

12 December 2020

Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group.

1 reference

12 December 2020

Familial breast cancer: collaborative reanalysis of individual data from 52 epidemiological studies including 58,209 women with breast cancer and 101,986 women without the disease

1 reference

12 December 2020

Determining carrier probabilities for breast cancer-susceptibility genes BRCA1 and BRCA2

1 reference

12 December 2020

Efficacy of bilateral prophylactic mastectomy in BRCA1 and BRCA2 gene mutation carriers

1 reference

12 December 2020

Subcutaneous mastectomy data: a final statistical analysis of 1500 patients

1 reference

12 December 2020

Breast self-examination and death from breast cancer: a meta-analysis

1 reference

12 December 2020

Comparison of breast magnetic resonance imaging, mammography, and ultrasound for surveillance of women at high risk for hereditary breast cancer

1 reference

12 December 2020

Molecular genetic characterization of BRCA1- and BRCA2-linked hereditary ovarian cancers.

1 reference

12 December 2020

Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations ofBRCA1

1 reference

12 December 2020

Breast and ovarian cancer

1 reference

12 December 2020

Magnetic resonance imaging and mammography in women with a hereditary risk of breast cancer.

1 reference

12 December 2020

Prevention and therapy for BRCA1/2 mutation carriers and women at high risk for breast and ovarian cancer

1 reference

12 December 2020

Tamoxifen and breast cancer incidence among women with inherited mutations in BRCA1 and BRCA2: National Surgical Adjuvant Breast and Bowel Project (NSABP-P1) Breast Cancer Prevention Trial.

1 reference

12 December 2020

Prophylactic oophorectomy in inherited breast/ovarian cancer families

1 reference

12 December 2020

Cancer risks in women with 2 breast or ovarian cancers: Clues to genetic cancer susceptibility

1 reference

12 December 2020

Evidence-based management options for women at increased breast/ovarian cancer risk

1 reference

12 December 2020

Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2

1 reference

12 December 2020

Improved survival in women with BRCA-associated ovarian carcinoma

1 reference

12 December 2020

Prophylactic mastectomy and inherited predisposition to breast carcinoma

1 reference

12 December 2020

Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations.

1 reference

12 December 2020

Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations

1 reference

12 December 2020

The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.

1 reference

12 December 2020

Efficacy of Bilateral Prophylactic Mastectomy in Women with a Family History of Breast Cancer

1 reference

12 December 2020

BRCA1 and BRCA2: 1994 and beyond

1 reference

12 December 2020

A breast cancer prediction model incorporating familial and personal risk factors.

1 reference

12 December 2020

Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group

1 reference

12 December 2020

Abstracts presented at the Breast Cancer Linkage Consortium (BCLC) and the International Collaborative Group on Familial Breast and Ovarian Cancer (ICG-FBOC) 14th General Meeting at the Centro Nacional de Investigaciones Oncológica (CNIO). Madrid, S

1 reference

12 December 2020

Primary peritoneal carcinoma after prophylactic oophorectomy in women with a family history of ovarian cancer. A report of the Gilda Radner Familial Ovarian Cancer Registry.

1 reference

12 December 2020

Survival in familial, BRCA1-associated, and BRCA2-associated epithelial ovarian cancer. United Kingdom Coordinating Committee for Cancer Research (UKCCCR) Familial Ovarian Cancer Study Group

1 reference

12 December 2020

Germ-line BRCA1 mutation is an adverse prognostic factor in Ashkenazi Jewish women with breast cancer.

1 reference

12 December 2020

Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study

1 reference

12 December 2020

Pathologic characteristics of breast parenchyma in patients with hereditary breast carcinoma, including BRCA1 and BRCA2 mutation carriers

1 reference

12 December 2020

Intra-abdominal carcinomatosis after prophylactic oophorectomy in ovarian-cancer-prone families

1 reference

12 December 2020

Linkage of early-onset familial breast cancer to chromosome 17q21

1 reference

12 December 2020

Genes other than BRCA1 and BRCA2 involved in breast cancer susceptibility

1 reference

12 December 2020

Chemoprevention of breast cancer: a literature review and report on the current status in Germany

1 reference

12 December 2020

Outcome of conservatively managed early-onset breast cancer by BRCA1/2 status

1 reference

12 December 2020

Autosomal dominant inheritance of early-onset breast cancer. Implications for risk prediction

1 reference

12 December 2020

Randomized trial of fenretinide to prevent second breast malignancy in women with early breast cancer.

1 reference

12 December 2020

Subcutaneous mastectomy is not a prophylaxis against carcinoma of the breast: opinion or knowledge?

1 reference

12 December 2020

Tubal ligation and risk of ovarian cancer in carriers of BRCA1 or BRCA2 mutations: a case-control study

1 reference

12 December 2020

Breast conservation therapy for invasive breast cancer in Ashkenazi women with BRCA gene founder mutations.

1 reference

12 December 2020

American Society of Clinical Oncology technology assessment on breast cancer risk reduction strategies: tamoxifen and raloxifene

1 reference

12 December 2020

Familial risks of breast cancer

1 reference

12 December 2020

BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells

1 reference

12 December 2020

Use of Genetic Testing and Prophylactic Mastectomy and Oophorectomy in Women With Breast or Ovarian Cancer From Families With a BRCA1 or BRCA2 Mutation

1 reference

12 December 2020

10.1007/S00109-005-0696-7

Identifiers

DOI

1 reference

13 August 2017

1 reference

PubMed ID

16283147